Proof-of-concept study to evaluate the safety and efficacy of saroglitazar in patients with primary biliary cholangitis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Proof-of-concept study to evaluate the safety and efficacy of saroglitazar in patients with primary biliary cholangitis
Authors
Keywords
-
Journal
JOURNAL OF HEPATOLOGY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-09-04
DOI
10.1016/j.jhep.2021.08.025
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A randomized placebo-controlled trial of elafibranor in patients with primary biliary cholangitis and incomplete response to UDCA.
- (2021) Jörn M. Schattenberg et al. JOURNAL OF HEPATOLOGY
- Saroglitazar, a PPAR‐α/γ Agonist, for Treatment of Nonalcoholic Fatty Liver Disease: A Randomized Controlled Double‐Blind Phase 2 Trial
- (2021) Samer Gawrieh et al. HEPATOLOGY
- Association of bezafibrate with transplant-free survival in patients with primary biliary cholangitis
- (2021) Atsushi Tanaka et al. JOURNAL OF HEPATOLOGY
- Goals of Treatment for Improved Survival in Primary Biliary Cholangitis
- (2020) Carla F. Murillo Perez et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis
- (2020) Christophe Corpechot et al. JOURNAL OF HEPATOLOGY
- Fenofibrate Improves Liver Function and Reduces the Toxicity of the Bile Acid Pool in Patients With Primary Biliary Cholangitis and Primary Sclerosing Cholangitis Who Are Partial Responders to Ursodiol
- (2020) Nisanne S. Ghonem et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Primary Biliary Cholangitis management: controversies, perspectives, and daily practice implications from an expert panel
- (2020) Domenico Alvaro et al. LIVER INTERNATIONAL
- Saroglitazar in patients with non-alcoholic fatty liver disease and diabetic dyslipidemia: a prospective, observational, real world study
- (2020) Omesh Goyal et al. Scientific Reports
- Autotaxin, bile acid profile and effect of ileal bile acid transporter inhibition in primary biliary cholangitis patients with pruritus
- (2019) Vinod S. Hegade et al. LIVER INTERNATIONAL
- Bezafibrate improves GLOBE and UK-PBC scores and long-term outcomes in patients with primary biliary cholangitis
- (2019) Akira Honda et al. HEPATOLOGY
- Validation of Risk Scoring Systems in Ursodeoxycholic Acid–Treated Patients With Primary Biliary Cholangitis
- (2019) Cumali Efe et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Additional fibrate treatment in UDCA‐refractory PBC patients
- (2019) Sung Won Chung et al. LIVER INTERNATIONAL
- The Potential Effects of Diabetes Mellitus on Liver Fibrosis in Patients with Primary Biliary Cholangitis
- (2019) Xu Liu et al. MEDICAL SCIENCE MONITOR
- Liver Injury in Patients with Cholestatic Liver Disease Treated with Obeticholic Acid
- (2019) John E Eaton et al. HEPATOLOGY
- Incidence, prevalence, and outcome of primary biliary cholangitis in a nationwide Swedish population-based cohort
- (2019) Hanns-Ulrich Marschall et al. Scientific Reports
- Primary biliary cholangitis: pathogenesis and therapeutic opportunities
- (2019) Aliya F. Gulamhusein et al. Nature Reviews Gastroenterology & Hepatology
- A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis
- (2018) Christophe Corpechot et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diagnosis and Management of Primary Biliary Cholangitis
- (2018) Zobair M. Younossi et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Pruritus is Common and Under-treated in Patients with Primary Biliary Cholangitis in the United Kingdom
- (2018) Vinod S. Hegade et al. Clinical Gastroenterology and Hepatology
- EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis
- (2017) Gideon M. Hirschfield et al. JOURNAL OF HEPATOLOGY
- Obeticholic Acid: First Global Approval
- (2016) A. Markham et al. DRUGS
- A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
- (2016) Frederik Nevens et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined ursodeoxycholic acid (UDCA) and fenofibrate in primary biliary cholangitis patients with incomplete UDCA response may improve outcomes
- (2015) A. C. Cheung et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Surrogate Endpoints for Optimal Therapeutic Response to UDCA in Primary Biliary Cholangitis
- (2015) Henk R. van Buuren et al. DIGESTIVE DISEASES
- Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy
- (2015) Willem J. Lammers et al. GASTROENTEROLOGY
- Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study
- (2015) Naga Chalasani et al. GASTROENTEROLOGY
- Fibrates and cholestasis
- (2015) Nisanne S. Ghonem et al. HEPATOLOGY
- Metabolic Syndrome Associated With Primary Biliary Cirrhosis
- (2015) Annarosa Floreani et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Levels of Alkaline Phosphatase and Bilirubin Are Surrogate End Points of Outcomes of Patients With Primary Biliary Cirrhosis: An International Follow-up Study
- (2014) Willem J. Lammers et al. GASTROENTEROLOGY
- Pharmacokinetics, Safety, and Tolerability of Saroglitazar (ZYH1), a Predominantly PPARα Agonist with Moderate PPARγ Agonist Activity in Healthy Human Subjects
- (2013) Rajendra H. Jani et al. CLINICAL DRUG INVESTIGATION
- Profiling Serum Bile Acid Glucuronides in Humans: Gender Divergences, Genetic Determinants, and Response to Fenofibrate
- (2013) J Trottier et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- A Multicenter, Prospective, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Saroglitazar 2 and 4 mg Compared with Placebo in Type 2 Diabetes Mellitus Patients Having Hypertriglyceridemia Not Controlled with Atorvastatin Therapy (PRESS VI)
- (2013) Rajendrakumar H. Jani et al. Diabetes Technology & Therapeutics
- Balanced pan-PPAR activator bezafibrate in combination with statin: comprehensive lipids control and diabetes prevention?
- (2012) Alexander Tenenbaum et al. Cardiovascular Diabetology
- Profile of Serum Bile Acids in Noncholestatic Volunteers: Gender-Related Differences in Response to Fenofibrate
- (2011) J Trottier et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Early primary biliary cirrhosis: Biochemical response to treatment and prediction of long-term outcome
- (2011) Christophe Corpechot et al. JOURNAL OF HEPATOLOGY
- Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis
- (2008) Christophe Corpechot et al. HEPATOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started